Karbe Frank
Phathom Pharmaceuticals, Inc. · Director
Karbe Frank is listed in public filings as director. This Karbe Frank insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Phathom Pharmaceuticals, Inc. (PHAT), and Cidara Therapeutics, Inc. (CDTX). Investors use Karbe Frank's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
Latest Actions
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| --91.6k shares | Grant / ExerciseMay 19, 2026 | Disclosure amount unavailable24.1k shares | -- | -- |
Insider Trades History
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $043.1k shares | OtherJan 7, 2026 | $9.6M43.1k shares | $221.50 | -- | |
| $0115k shares | OtherJan 7, 2026 | $2.4M115k shares | $20.50 | -- | |
| $9.6M43.1k shares | OtherJan 7, 2026 | $1.7M7.5k shares | $221.50 | -- | |
| $11M50.6k shares | Grant / ExerciseDec 10, 2025 | $1.6M7.3k shares | $219.60 | -- | |
| --67.5k shares | Grant / ExerciseJun 3, 2025 | Disclosure amount unavailable10.5k shares | -- | -- | |
| $87k17.5k shares | Grant / ExerciseJun 3, 2025 | $86.6K17.5k shares | $4.95 | -- | |
| $2.4M115k shares | Grant / ExerciseFeb 24, 2025 | $2.4M115k shares | $20.50 | -- | |
| --57.5k shares | Grant / ExerciseFeb 24, 2025 | Disclosure amount unavailable57.5k shares | -- | -- | |
| $452k57k shares | BuyDec 13, 2024 | $99.1K12.5k shares | $7.93 | -- |